Zogenix Raises $50 Million in Equity, Debt

Zogenix Inc., a San Diego-based drug company focused on pain management and CNS disorders, has raised $15 million in Series C funding. Return backers include Clarus Ventures, Domain Associates, Scale Venture Partners, Thomas, McNerney & Partners, Abingworth Management and Chicago Growth Partners. The company previously had raised $71 million, and today also announced that it has secured a $35 million debt facility from Oxford Finance Corp. and Silicon Valley Bank.

North AmericaUSBriefs